Role of itaconate in intestinal disease (Review)

Read full text
Authors: Xin Li, Q. Liu, Jiajia Li, Li Zhang, Shun Yao, Lulu Tang, Bingqi Yang, Yongfeng Wang, Guorong Wen, Jiaxing An, Hai Jin, Biguang Tuo
Cited by: 1
References: 146

Abstract

Itaconate (ITA) is a metabolite produced by immune cells such as macrophages during inflammation or infection.ITA exhibits potent immunomodulatory functions, antioxidant effects and antibacterial properties.The present study aimed to provide a systematic review of the synthesis and metabolic regulatory mechanisms of ITA and its key roles in intestinal diseases.ITA affects inflammatory bowel disease (IBD), colorectal cancer (CRC), intestinal infection and other gut disorders via the regulation of signalling pathways, including the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome, NF-κB and Nrf2 pathways.ITA also modulates the composition of the gut microbiota and enhances intestinal barrier function.The present study also aimed to summarize the therapeutic potential of ITA derivatives, providing a theoretical basis for the development of novel treatment strategies for intestinal disease.Contents 1. Introduction 2. Discovery and molecular structure of ITA 3. Synthesis and metabolism of ITA 4. Role of ITA 5. Role of ITA in intestinal disease 6. Clinical prospects and challenges of ITA derivatives 7.

Fields of Study & Subjects

Inflammatory Bowel Disease Microscopic Colitis Clostridium difficile and Clostridium perfringens research

Publication details

Journal / source
International Journal of Molecular Medicine
Publisher
Spandidos Publications
Volume
57
Issue
6
Pages
1–15
Publication date
27 March 2026
Language
EN